| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |